VistaGen Therapeutics Financial Overview
VistaGen Therapeutics's market cap is currently $30.72M. The company's EPS TTM is $-0.54; its P/E ratio is -0.49; VistaGen Therapeutics is scheduled to report earnings on November 13, 2025, and the estimated EPS forecast is $-0.49. See an overview of income statement, balance sheet, and cash flow financials.
